Live Update 
From the Liveblog of
Tuesday, November 16, 2021
From the Liveblog of
Tuesday, November 16, 2021
Pfizer announces licensing deal to make COVID drug pill cheaper in poor countries
Add ToI as a Preferred Source on Google
This Feb. 5, 2021, file photo shows the Pfizer logo displayed at the company's headquarters in New York. Pfizer says its experimental pill for COVID-19 cut rates of hospitalization and death by nearly 90% among patients with mild-to-moderate infections. (AP Photo/Mark Lennihan, File)
GENEVA — US pharmaceutical giant Pfizer announces a deal to make its oral antiviral COVID-19 medication available more cheaply in poorer countries, if it passes trials and regulatory approval.
The deal with the global Medicines Patent Pool (MPP) will make the candidate drug available at a lower cost in 95 low- and middle-income countries covering around 53 percent of the world’s population.
If you’d like to comment, join
The Times of Israel Community.
The Times of Israel Community.
JOIN THE TOI COMMUNITY
Already a member? Log in here